Mirum Pharmaceuticals Statistics
NASDAQ: MIRMHealth CareBiotechnology: Pharmaceutical PreparationsUSD
79.52-1.12 (-1.39%)
Market open · Delayed 15 min · as of Oct 8, 12:43 PM ET
Mirum Pharmaceuticals by the numbers
Mirum Pharmaceuticals has a market capitalization of $5.16 billion based on 64.93M shares outstanding. With trailing EPS of $-14.10, Mirum Pharmaceuticals is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 17.4% below its 50-day average and 19.2% below its 200-day average.
Average daily trading volume is 698.74K shares, or about $55.6 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
MIRM valuation vs. peer median
| Metric | MIRM | Peer median | Difference |
|---|---|---|---|
| Market cap | $5.16B | $5.09B | +1% |
| Avg. volume | 698.74K | 981.99K | -29% |
Peer median across 8 companies: ERAS, PTCT, COGT, GRFS, TVTX, MANE, LGND, DNTH.
Valuation
- Market cap
- $5.16B
- Price / sales (latest FY)
- 9.90
- EPS (TTM)
- $-14.10
- Shares outstanding
- 64.93M
Price and trading
- Previous close
- 80.64
- Open
- 80.31
- Day range
- 78.63 – 80.76
- 52-week range
- 63.23 – 130.00
- 52-week change
- +9.36%
- Beta
- —
- Volume
- 186.22K
- Average volume
- 698.74K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 3, 2026
Additional statistics
- Market Cap
- 5.16B
- Forward Pe
- -229.38
- Eps
- -14.10
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 130.00
- Week52 Low
- 63.23
- Avg Volume
- 698.74K
- Shares Outstanding
- 64.93M
- Ma50
- 96.23
- Ma200
- 98.43
- Earnings Date
- Nov 3, 2026
- Pct From52w High
- -38.83%
- Pct From52w Low
- 25.76%